Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.

The company develops, manufactures, distributes, and sells technologies and devices for cataract, retinal, refractive surgery, as well as contact lenses and lens care products. Read More on ALC: Alcon ...

Alcon Inc (ALC) reports strong international growth and prepares for new product launches despite facing competitive pressures in the US market.

We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...

Yesterday, Alcon was alerted that our third quarter earnings press ... I’m also excited to announce that we’ve completed the migration of all of our intraocular lenses, including PanOptix, Vivity, and ...

ALC's performance is driven by robust demand for the company's innovative products, balanced geographic footprint and strong ...

Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...

Third-quarter 2024 sales of $2.4 billion, up 6% on a reported and constant currency1 (cc) basis Third-quarter 2024 diluted EPS of $0.53, up 29%, or 32% cc; core diluted EPS2 of $0.81, up 23% ...

The annual China International Import Expo (CIIE) taking place in Shanghai serves as a prime platform for foreign companies to showcase innovations, breakthrough technologies, and quality products; ...